AMGEN presents data on rare disease drugs at european medical congress

June 3, 2026 9:01 AM

Amgen (NASDAQ: AMGN) announced presentations of new clinical data for its rare autoimmune and inflammatory disease treatments at the European ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found